Rights and permissions
About this article
Cite this article
Slow-release lanreotide plus interferon-α-2b (IFN-α-2b) relieves symptoms in patients with advanced medullary thyroid cancer,. Inpharma Wkly. 1223, 17 (2000). https://doi.org/10.2165/00128413-200012230-00041
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200012230-00041